During the past decade, Hospital San Juan de Alicante conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 7 clinical trials were completed, i.e. on average, 38.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital San Juan de Alicante" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Hospital Arnau de Vilanova" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Fundación EPIC" with 2 trials sponsored and "Universidad Miguel Hernandez de Elche" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital San Juan de Alicante" #1 collaborator was "Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Hospital Universitario San Juan de Alicante" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Hospital San Juan de Alicante" are "Coronary Artery Disease" (6 trials), "Dyslipidemia" (4 trials), "Atrial Fibrillation" (3 trials), "Hypercholesterolemia" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Hospital San Juan de Alicante" in a lesser frequency.

Most popular intervention types in "Hospital San Juan de Alicante" are "Drug" (17 trials), "Device" (4 trials), "Other" (4 trials), "Diagnostic Test" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine and Docetaxel" (2 trials), "Pitavastatin" (2 trials), "Placebo" (2 trials), "pitavastatin" (2 trials) and "simvastatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital San Juan de Alicante" are 32 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital San Juan de Alicante". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Hospital San Juan de Alicante, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital San Juan de Alicante, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".